More settlement news

Following up on the story from a few days ago, Pharmalot is reporting that AstraZeneca is moving closer to resolving the large number of lawsuits filed in the US over claims that the risks of its Seroquel antipsychotic were not properly disclosed. In the latest disclosure, AstraZeneca has agreed to pay about $198 million to settle 17,500, or roughly two-thirds of the outstanding lawsuits. Go here for the full story. Law.com also has more on the story here.